{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:46:26Z","timestamp":1789181186531,"version":"build-2803163510"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Province Postgraduate Research and Practice Innovation Program","award":["SJCX24_1035"],"award-info":[{"award-number":["SJCX24_1035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28358-y","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:28:16Z","timestamp":1766582896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unraveling the mechanism of curcumin in coronary slow flow phenomenon through network pharmacology and molecular docking"],"prefix":"10.1038","volume":"15","author":[{"given":"Chentian","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xize","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"1","key":"28358_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0002-8703(72)90307-9","volume":"84","author":"AA Tambe","year":"1972","unstructured":"Tambe, A. A., Demany, M. A., Zimmerman, H. A. & Mascarenhas, E. Angina pectoris and slow flow velocity of dye in coronary arteries\u2013a new angiographic finding. Am. Heart J. 84 (1), 66\u201371 (1972).","journal-title":"Am. Heart J."},{"issue":"1","key":"28358_CR2","first-page":"37","volume":"1","author":"X Wang","year":"2011","unstructured":"Wang, X. & Nie, S. P. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc. Diagn. Ther. 1 (1), 37\u201343 (2011).","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"4","key":"28358_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000063121","volume":"97","author":"JF Beltrame","year":"2002","unstructured":"Beltrame, J. F., Limaye, S. B. & Horowitz, J. D. The coronary slow flow phenomenon\u2013a new coronary microvascular disorder. Cardiology 97 (4), 197\u2013202 (2002).","journal-title":"Cardiology"},{"issue":"7","key":"28358_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.5152\/akd.2014.5578","volume":"15","author":"MA Sadr-Ameli","year":"2015","unstructured":"Sadr-Ameli, M. A. et al. Coronary slow flow: benign or ominous? Anatol. J. Cardiol. 15 (7), 531\u2013535 (2015).","journal-title":"Anatol. J. Cardiol."},{"issue":"5","key":"28358_CR5","first-page":"462","volume":"16","author":"B Wozakowska-Kap\u0142on","year":"2009","unstructured":"Wozakowska-Kap\u0142on, B., Niedziela, J., Krzyzak, P. & Stec, S. Clinical manifestations of slow coronary flow from acute coronary syndrome to serious arrhythmias. Cardiol. J. 16 (5), 462\u2013468 (2009).","journal-title":"Cardiol. J."},{"key":"28358_CR6","doi-asserted-by":"crossref","unstructured":"Zhu, X. et al. Clinical Profile and Outcome in Patients with Coronary Slow Flow Phenomenon. Cardiol Res Pract. ; 2019: 9168153. (2019).","DOI":"10.1155\/2019\/9168153"},{"issue":"1","key":"28358_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000109405","volume":"110","author":"M Cakmak","year":"2008","unstructured":"Cakmak, M. et al. Simvastatin May improve myocardial perfusion abnormality in slow coronary flow. Cardiology 110 (1), 39\u201344 (2008).","journal-title":"Cardiology"},{"issue":"9","key":"28358_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/clc.20140","volume":"30","author":"M Caliskan","year":"2007","unstructured":"Caliskan, M. et al. Effects of Atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin. Cardiol. 30 (9), 475\u2013479 (2007).","journal-title":"Clin. Cardiol."},{"issue":"1","key":"28358_CR9","first-page":"904","volume":"15","author":"H Niu","year":"2018","unstructured":"Niu, H., Wei, Z., Zhang, Y., He, J. & Jia, D. Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow. Exp. Ther. Med. 15 (1), 904\u2013908 (2018).","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"28358_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1536\/ihj.50.545","volume":"50","author":"S Albayrak","year":"2009","unstructured":"Albayrak, S. et al. Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow. Int. Heart J. 50 (5), 545\u2013553 (2009).","journal-title":"Int. Heart J."},{"issue":"10","key":"28358_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.5603\/KP.a2016.0060","volume":"74","author":"H Simsek","year":"2016","unstructured":"Simsek, H. et al. Decreased risk of ventricular arrhythmias with treatment of nebivolol in patients with coronary slow flow. Kardiol Pol. 74 (10), 1174\u20131179 (2016).","journal-title":"Kardiol Pol."},{"issue":"6","key":"28358_CR12","doi-asserted-by":"publisher","first-page":"e38851","DOI":"10.1371\/journal.pone.0038851","volume":"7","author":"L Li","year":"2012","unstructured":"Li, L. et al. A randomized, single-center double-blinded trial on the effects of diltiazem sustained-release capsules in patients with coronary slow flow phenomenon at 6-month follow-up. PLoS One. 7 (6), e38851 (2012).","journal-title":"PLoS One"},{"issue":"4","key":"28358_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/1074248415571457","volume":"20","author":"HD Sani","year":"2015","unstructured":"Sani, H. D. et al. Nicorandil versus nitroglycerin for symptomatic relief of angina in patients with slow coronary flow phenomenon: A randomized clinical trial. J. Cardiovasc. Pharmacol. Ther. 20 (4), 401\u2013406 (2015).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"5","key":"28358_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/jcm13051337","volume":"13","author":"S Pasupathy","year":"2024","unstructured":"Pasupathy, S. et al. Anti-Anginal efficacy of Zibotentan in the coronary Slow-Flow phenomenon. J. Clin. Med. 13 (5), 1337 (2024).","journal-title":"J. Clin. Med."},{"issue":"5","key":"28358_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MCA.0000000000000373","volume":"27","author":"A Suner","year":"2016","unstructured":"Suner, A. & Cetin, M. The effect of Trimetazidine on ventricular repolarization indexes and left ventricular diastolic function in patients with coronary slow flow. Coron. Artery Dis. 27 (5), 398\u2013404 (2016).","journal-title":"Coron. Artery Dis."},{"issue":"4","key":"28358_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00380-010-0058-4","volume":"26","author":"U Guntekin","year":"2011","unstructured":"Guntekin, U. et al. The effects of Perindopril on QT duration and dispersion in patients with coronary slow flow. Heart Vessels. 26 (4), 357\u2013362 (2011).","journal-title":"Heart Vessels"},{"key":"28358_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/DDDT.S445555","volume":"18","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Review of the protective mechanism of Curcumin on cardiovascular disease. Drug Des. Devel Ther. 18, 165\u2013192 (2024).","journal-title":"Drug Des. Devel Ther."},{"key":"28358_CR18","doi-asserted-by":"publisher","first-page":"111888","DOI":"10.1016\/j.biopha.2021.111888","volume":"141","author":"YS Fu","year":"2021","unstructured":"Fu, Y. S. et al. Pharmacological properties and underlying mechanisms of Curcumin and prospects in medicinal potential. Biomed. Pharmacother. 141, 111888 (2021).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"28358_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13063-024-08354-9","volume":"25","author":"M Soltani","year":"2024","unstructured":"Soltani, M. et al. Effect of nano-curcumin supplementation on cardiometabolic risk factors, physical and psychological quality of life, and depression in patients with coronary slow flow phenomenon: a randomized double-blind clinical trial. Trials 25 (1), 515 (2024).","journal-title":"Trials"},{"issue":"1","key":"28358_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40795-024-00877-3","volume":"10","author":"M Rezaei","year":"2024","unstructured":"Rezaei, M. et al. Effect of nano-curcumin supplementation on angina status, and traditional and novel cardiovascular risk factors in overweight or obese patients with coronary slow flow phenomenon: a randomized double-blind placebo-controlled clinical trial. BMC Nutr. 10 (1), 73 (2024).","journal-title":"BMC Nutr."},{"key":"28358_CR21","doi-asserted-by":"crossref","unstructured":"Unhapipatpong, C. et al. An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Controlled Trials Investigating the Effect of Curcumin Supplementation on Lipid Profiles. Nutr Rev 83(8), nuaf012 (2025).","DOI":"10.1093\/nutrit\/nuaf012"},{"key":"28358_CR22","doi-asserted-by":"publisher","first-page":"107641","DOI":"10.1016\/j.phrs.2025.107641","volume":"213","author":"G Wilar","year":"2025","unstructured":"Wilar, G. et al. Effects of Nanocurcumin supplementation on metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 213, 107641 (2025).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"28358_CR23","first-page":"1","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang, X., Wang, Z. Y., Zheng, J. H. & Li, S. TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches. Chin. J. Nat. Med. 19 (1), 1\u201311 (2021).","journal-title":"Chin. J. Nat. Med."},{"key":"28358_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijbiomac.2022.03.021","volume":"208","author":"VK Bhardwaj","year":"2022","unstructured":"Bhardwaj, V. K., Oakley, A. & Purohit, R. Mechanistic behavior and subtle key events during DNA clamp opening and closing in T4 bacteriophage. Int. J. Biol. Macromol. 208, 11\u201319 (2022).","journal-title":"Int. J. Biol. Macromol."},{"issue":"11","key":"28358_CR25","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1002\/jcb.25555","volume":"117","author":"B Kamaraj","year":"2016","unstructured":"Kamaraj, B. & Purohit, R. Mutational analysis on membrane associated transporter protein (MATP) and their structural consequences in oculocutaeous albinism type 4 (OCA4)-A molecular dynamics approach. J. Cell. Biochem. 117 (11), 2608\u20132619 (2016).","journal-title":"J. Cell. Biochem."},{"key":"28358_CR26","doi-asserted-by":"publisher","first-page":"121162","DOI":"10.1016\/j.carbpol.2023.121162","volume":"319","author":"P Kumar","year":"2023","unstructured":"Kumar, P., Bhardwaj, V. K. & Purohit, R. Dispersion-corrected DFT calculations and umbrella sampling simulations to investigate stability of Chrysin-cyclodextrin inclusion complexes. Carbohydr. Polym. 319, 121162 (2023).","journal-title":"Carbohydr. Polym."},{"issue":"D1","key":"28358_CR27","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim, S. et al. PubChem 2025 update. Nucleic Acids Res. 53 (D1), D1516\u2013D1525 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"28358_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s42004-024-01179-2","volume":"7","author":"A Daina","year":"2024","unstructured":"Daina, A. & Zoete, V. Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning. Commun. Chem. 7 (1), 105 (2024).","journal-title":"Commun. Chem."},{"issue":"5","key":"28358_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10822-016-9915-2","volume":"30","author":"ZJ Yao","year":"2016","unstructured":"Yao, Z. J. et al. TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models. J. Comput. Aided Mol. Des. 30 (5), 413\u2013424 (2016).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"D1","key":"28358_CR30","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. TTD: therapeutic target database describing target druggability information. Nucleic Acids Res. 52 (D1), D1465\u2013D1477 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"28358_CR31","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang, X. et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 45 (W1), W356\u2013W360 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"28358_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser, M. J. et al. Relating protein Pharmacology by ligand chemistry. Nat. Biotechnol. 25 (2), 197\u2013206 (2007).","journal-title":"Nat. Biotechnol."},{"key":"28358_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The genecards suite: from gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinf. 54, 1 (2016). 30.31.","journal-title":"Curr. Protoc. Bioinf."},{"issue":"D1","key":"28358_CR34","doi-asserted-by":"publisher","first-page":"D1038","DOI":"10.1093\/nar\/gky1151","volume":"47","author":"JS Amberger","year":"2019","unstructured":"Amberger, J. S., Bocchini, C. A., Scott, A. F. & Hamosh, A. OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res. 47 (D1), D1038\u2013D1043 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28358_CR35","doi-asserted-by":"publisher","first-page":"D948","DOI":"10.1093\/nar\/gkae1071","volume":"53","author":"SC Dyer","year":"2025","unstructured":"Dyer, S. C. et al. Ensembl 2025. Nucleic Acids Res. 53 (D1), D948\u2013D957 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28358_CR36","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"28358_CR37","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50 (W1), W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"28358_CR38","unstructured":"Aleksander, S. A. et al. The gene ontology knowledgebase in 2023. Genetics  224(1), iyad031 (2023)."},{"issue":"11","key":"28358_CR39","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS One. 18 (11), e0294236 (2023).","journal-title":"PLoS One"},{"issue":"W1","key":"28358_CR40","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz, M. et al. GeneMANIA update 2018. Nucleic Acids Res. 46 (W1), W60\u2013W64 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28358_CR41","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51 (D1), D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"28358_CR42","doi-asserted-by":"publisher","first-page":"W203","DOI":"10.1093\/nar\/gkaf365","volume":"53","author":"K Ono","year":"2025","unstructured":"Ono, K. et al. Cytoscape web: bringing network biology to the browser. Nucleic Acids Res. 53 (W1), W203\u2013W212 (2025).","journal-title":"Nucleic Acids Res."},{"key":"28358_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader, G. D. & Hogue, C. W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 4, 2 (2003).","journal-title":"BMC Bioinform."},{"issue":"Suppl 4(Suppl 4","key":"28358_CR44","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 (Suppl 4(Suppl 4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"issue":"D1","key":"28358_CR45","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han, H. et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46 (D1), D380\u2013d386 (2018).","journal-title":"Nucleic Acids Res."},{"key":"28358_CR46","doi-asserted-by":"publisher","first-page":"e05005","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal, V., Bell, G. W., Nam, J. W. & Bartel, D. P. Predicting effective MicroRNA target sites in mammalian mRNAs. Elife 4, e05005 (2015).","journal-title":"Elife"},{"issue":"W1","key":"28358_CR47","doi-asserted-by":"publisher","first-page":"W148","DOI":"10.1093\/nar\/gkad283","volume":"51","author":"S Tastsoglou","year":"2023","unstructured":"Tastsoglou, S. et al. DIANA-microT 2023: including predicted targets of virally encoded MiRNAs. Nucleic Acids Res. 51 (W1), W148\u2013W153 (2023).","journal-title":"Nucleic Acids Res."},{"key":"28358_CR48","doi-asserted-by":"publisher","first-page":"W165","DOI":"10.1093\/nar\/gkt430","volume":"41","author":"CE Vejnar","year":"2013","unstructured":"Vejnar, C. E., Blum, M. & Zdobnov, E. M. MiRmap web: comprehensive MicroRNA target prediction online. Nucleic Acids Res. 41, W165\u2013168 (2013). (Web Server issue).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"28358_CR49","doi-asserted-by":"publisher","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","volume":"52","author":"G Skoufos","year":"2024","unstructured":"Skoufos, G. et al. TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally encoded MiRNAs. Nucleic Acids Res. 52 (D1), D304\u2013D310 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"28358_CR50","doi-asserted-by":"publisher","first-page":"021101","DOI":"10.1063\/4.0000302","volume":"12","author":"J Iwasa","year":"2025","unstructured":"Iwasa, J., Goodsell, D. S., Burley, S. K. & Zardecki, C. A new chapter for RCSB protein data bank molecule of the month in 2025. Struct. Dyn. 12 (2), 021101 (2025).","journal-title":"Struct. Dyn."},{"issue":"2","key":"28358_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of Docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31 (2), 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"issue":"12","key":"28358_CR52","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/biom12121764","volume":"12","author":"S Rosignoli","year":"2022","unstructured":"Rosignoli, S. & Paiardini, A. Boosting the full potential of PyMOL with structural biology plugins. Biomolecules 12 (12), 1764 (2022).","journal-title":"Biomolecules"},{"issue":"7","key":"28358_CR53","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29 (7), 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"key":"28358_CR54","doi-asserted-by":"crossref","unstructured":"Abourehab, M. A. S. et al. Insights into their Syntheses, target Kinases, biological Activities, receptor Interactions, and metabolism. Molecules 26(21), 6677 (2021).","DOI":"10.3390\/molecules26216677"},{"issue":"9162","key":"28358_CR55","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/S0140-6736(05)75961-4","volume":"353","author":"I Bjarnason","year":"1999","unstructured":"Bjarnason, I. COX-2 inhibitors. Lancet 353 (9162), 1440 (1999).","journal-title":"Lancet"},{"issue":"11","key":"28358_CR56","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust, J., Sperl, B., Hollis, A., Mayer, T. U. & Berg, T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 13 (11), 1235\u20131242 (2006).","journal-title":"Chem. Biol."},{"issue":"10","key":"28358_CR57","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.7150\/ijbs.115032","volume":"21","author":"L Li","year":"2025","unstructured":"Li, L. et al. BAY11-7082 targets RNF25 to reverse TRIP4 Ubiquitination-dependent NF-\u03baB activation and apoptosis resistance in renal cell carcinoma. Int. J. Biol. Sci. 21 (10), 4410\u20134427 (2025).","journal-title":"Int. J. Biol. Sci."},{"issue":"1\u20132","key":"28358_CR58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0022-1759(03)00176-5","volume":"277","author":"JR Woska Jr","year":"2003","unstructured":"Woska, J. R. Jr. et al. Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay. J. Immunol. Methods. 277 (1\u20132), 101\u2013115 (2003).","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"28358_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1536\/ihj.46.373","volume":"46","author":"N Sezgin","year":"2005","unstructured":"Sezgin, N. et al. Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int. Heart J. 46 (3), 373\u2013382 (2005).","journal-title":"Int. Heart J."},{"issue":"12","key":"28358_CR60","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1253\/circj.67.1022","volume":"67","author":"A Camsarl","year":"2003","unstructured":"Camsarl, A. et al. Endothelin-1 and nitric oxide concentrations and their response to exercise in patients with slow coronary flow. Circ. J. 67 (12), 1022\u20131028 (2003).","journal-title":"Circ. J."},{"issue":"9\u201310","key":"28358_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5830\/CVJA-2013-072","volume":"24","author":"H Ta\u015folar","year":"2013","unstructured":"Ta\u015folar, H. et al. Endothelial nitric oxide synthase levels and their response to exercise in patients with slow coronary flow. Cardiovasc. J. Afr. 24 (9\u201310), 355\u2013359 (2013).","journal-title":"Cardiovasc. J. Afr."},{"issue":"4","key":"28358_CR62","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1253\/circj.CJ-11-0959","volume":"76","author":"BM Hawkins","year":"2012","unstructured":"Hawkins, B. M., Stavrakis, S., Rousan, T. A., Abu-Fadel, M. & Schechter, E. Coronary slow flow\u2013prevalence and clinical correlations. Circ. J. 76 (4), 936\u2013942 (2012).","journal-title":"Circ. J."},{"issue":"5","key":"28358_CR63","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2143\/AC.63.5.2033224","volume":"63","author":"H Yilmaz","year":"2008","unstructured":"Yilmaz, H., Demir, I. & Uyar, Z. Clinical and coronary angiographic characteristics of patients with coronary slow flow. Acta Cardiol. 63 (5), 579\u2013584 (2008).","journal-title":"Acta Cardiol."},{"key":"28358_CR64","doi-asserted-by":"crossref","unstructured":"Oliver, J. M. et al. Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study. J Nutr Metab. ; 2016: 1089653. (2016).","DOI":"10.1155\/2016\/1089653"},{"issue":"1","key":"28358_CR65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.18632\/aging.101149","volume":"9","author":"JR Santos-Parker","year":"2017","unstructured":"Santos-Parker, J. R. et al. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging (Albany NY). 9 (1), 187\u2013208 (2017).","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"28358_CR66","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1536\/jhj.44.907","volume":"44","author":"VG Cin","year":"2003","unstructured":"Cin, V. G. et al. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 44 (6), 907\u2013919 (2003).","journal-title":"Jpn Heart J."},{"issue":"12","key":"28358_CR67","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1111\/echo.14540","volume":"36","author":"R Dong","year":"2019","unstructured":"Dong, R. et al. Carotid artery blood velocity decreases in patients with coronary slow flow: A manifestation of systemic arteriosclerosis. Echocardiography 36 (12), 2234\u20132240 (2019).","journal-title":"Echocardiography"},{"key":"28358_CR68","doi-asserted-by":"publisher","first-page":"913399","DOI":"10.3389\/fphys.2022.913399","volume":"13","author":"Y Bai","year":"2022","unstructured":"Bai, Y. et al. Efficacy of Shexiang Tongxin dropping pills in a swine model of coronary slow flow. Front. Physiol. 13, 913399 (2022).","journal-title":"Front. Physiol."},{"issue":"4","key":"28358_CR69","doi-asserted-by":"publisher","first-page":"525","DOI":"10.21470\/1678-9741-2020-0573","volume":"37","author":"H Jiang","year":"2022","unstructured":"Jiang, H. et al. Long noncoding RNA AF131217.1 regulated coronary slow flow-Induced inflammation affecting coronary slow flow via KLF4. Braz J. Cardiovasc. Surg. 37 (4), 525\u2013533 (2022).","journal-title":"Braz J. Cardiovasc. Surg."},{"issue":"1\u20132","key":"28358_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2007.05.024","volume":"385","author":"JJ Li","year":"2007","unstructured":"Li, J. J. et al. Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin. Chim. Acta. 385 (1\u20132), 43\u201347 (2007).","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"28358_CR71","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijcard.2005.05.008","volume":"108","author":"H Turhan","year":"2006","unstructured":"Turhan, H. et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int. J. Cardiol. 108 (2), 224\u2013230 (2006).","journal-title":"Int. J. Cardiol."},{"key":"28358_CR72","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.2147\/JIR.S312583","volume":"14","author":"Q Zhu","year":"2021","unstructured":"Zhu, Q. et al. LncRNA NEAT1 promote inflammatory responses in coronary slow flow through regulating miR-148b-3p\/ICAM-1 axis. J. Inflamm. Res. 14, 2445\u20132463 (2021).","journal-title":"J. Inflamm. Res."},{"issue":"5","key":"28358_CR73","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12012-024-09855-4","volume":"24","author":"M Kaplangoray","year":"2024","unstructured":"Kaplangoray, M., Toprak, K., Deveci, E., Caglayan, C. & \u015eahin, E. Could Pan-Immune-Inflammation value be a marker for the diagnosis of coronary slow flow phenomenon? Cardiovasc. Toxicol. 24 (5), 519\u2013526 (2024).","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"28358_CR74","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/acs.jafc.7b04260","volume":"66","author":"S Zhang","year":"2018","unstructured":"Zhang, S., Zou, J., Li, P., Zheng, X. & Feng, D. Curcumin protects against atherosclerosis in Apolipoprotein E-Knockout mice by inhibiting Toll-like receptor 4 expression. J. Agric. Food Chem. 66 (2), 449\u2013456 (2018).","journal-title":"J. Agric. Food Chem."},{"issue":"12","key":"28358_CR75","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s00011-011-0381-y","volume":"60","author":"DC Kim","year":"2011","unstructured":"Kim, D. C., Lee, W. & Bae, J. S. Vascular anti-inflammatory effects of Curcumin on HMGB1-mediated responses in vitro. Inflamm. Res. 60 (12), 1161\u20131168 (2011).","journal-title":"Inflamm. Res."},{"issue":"4","key":"28358_CR76","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000363451","volume":"23","author":"E Gazi","year":"2014","unstructured":"Gazi, E. et al. Intercellular adhesion molecule-1 K469E and angiotensinogen T207M polymorphisms in coronary slow flow. Med. Princ Pract. 23 (4), 346\u2013350 (2014).","journal-title":"Med. Princ Pract."},{"key":"28358_CR77","doi-asserted-by":"publisher","first-page":"155511","DOI":"10.1016\/j.cyto.2021.155511","volume":"143","author":"N Roshanravan","year":"2021","unstructured":"Roshanravan, N. et al. A novel inflammatory signaling pathway in patients with slow coronary flow: NF-\u03baB\/IL-1\u03b2\/nitric oxide. Cytokine 143, 155511 (2021).","journal-title":"Cytokine"},{"key":"28358_CR78","doi-asserted-by":"publisher","first-page":"45917","DOI":"10.1038\/srep45917","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci. Rep. 8, 45917 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"28358_CR79","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1161\/ATVBAHA.117.309927","volume":"38","author":"L Zeboudj","year":"2018","unstructured":"Zeboudj, L. et al. Selective EGFR (Epidermal growth factor Receptor) deletion in myeloid cells limits Atherosclerosis-Brief report. Arterioscler. Thromb. Vasc Biol. 38 (1), 114\u2013119 (2018).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"issue":"4","key":"28358_CR80","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/cells12040612","volume":"12","author":"K Miyazaki","year":"2023","unstructured":"Miyazaki, K. et al. Curcumin-Mediated resistance to lenvatinib via EGFR signaling pathway in hepatocellular carcinoma. Cells 12 (4), 612 (2023).","journal-title":"Cells"},{"issue":"8","key":"28358_CR81","doi-asserted-by":"publisher","first-page":"e23756","DOI":"10.1371\/journal.pone.0023756","volume":"6","author":"JY Lee","year":"2011","unstructured":"Lee, J. Y. et al. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PLoS One. 6 (8), e23756 (2011).","journal-title":"PLoS One"},{"key":"28358_CR82","doi-asserted-by":"publisher","first-page":"108264","DOI":"10.1016\/j.bioorg.2025.108264","volume":"157","author":"JF Cao","year":"2025","unstructured":"Cao, J. F. et al. Insights into curcumin\u2019s anticancer activity in pancreatic ductal adenocarcinoma: experimental and computational evidence targeting HRAS, CCND1, EGFR and AKT1. Bioorg. Chem. 157, 108264 (2025).","journal-title":"Bioorg. Chem."},{"issue":"1","key":"28358_CR83","doi-asserted-by":"publisher","first-page":"17344","DOI":"10.1038\/s41598-024-67776-2","volume":"14","author":"Q Li","year":"2024","unstructured":"Li, Q. et al. Target analysis and identification of Curcumin against vascular calcification. Sci. Rep. 14 (1), 17344 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"28358_CR84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","volume":"61","author":"C Lawson","year":"2009","unstructured":"Lawson, C. & Wolf, S. ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 61 (1), 22\u201332 (2009).","journal-title":"Pharmacol. Rep."},{"key":"28358_CR85","doi-asserted-by":"publisher","first-page":"117487","DOI":"10.1016\/j.cca.2023.117487","volume":"548","author":"V Singh","year":"2023","unstructured":"Singh, V., Kaur, R., Kumari, P., Pasricha, C. & Singh, R. ICAM-1 and VCAM-1: gatekeepers in various inflammatory and cardiovascular disorders. Clin. Chim. Acta. 548, 117487 (2023).","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"28358_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12291-019-00858-5","volume":"36","author":"ML Majeed","year":"2021","unstructured":"Majeed, M. L., Ghafil, F. A., Fatima, G., Hadi, N. R. & Mahdi, H. F. Anti-Atherosclerotic and Anti-Inflammatory effects of Curcumin on hypercholesterolemic male rabbits. Indian J. Clin. Biochem. 36 (1), 74\u201380 (2021).","journal-title":"Indian J. Clin. Biochem."},{"key":"28358_CR87","doi-asserted-by":"publisher","first-page":"960327121106904","DOI":"10.1177\/09603271211069043","volume":"41","author":"Y Liu","year":"2022","unstructured":"Liu, Y., Li, X. & Zhao, Y. Curcumin alleviated lipopolysaccharide-evoked H9c2 cells damage via suppression of intercellular adhesion molecule 1\/CD40\/NF-\u03baB signaling. Hum. Exp. Toxicol. 41, 9603271211069043 (2022).","journal-title":"Hum. Exp. Toxicol."},{"issue":"11","key":"28358_CR88","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1152\/physiolgenomics.00086.2017","volume":"49","author":"A Alexanian","year":"2017","unstructured":"Alexanian, A. & Sorokin, A. Cyclooxygenase 2: protein-protein interactions and posttranslational modifications. Physiol. Genomics. 49 (11), 667\u2013681 (2017).","journal-title":"Physiol. Genomics"},{"issue":"4","key":"28358_CR89","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2337\/db07-1204","volume":"57","author":"N Shanmugam","year":"2008","unstructured":"Shanmugam, N. et al. Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 57 (4), 879\u2013888 (2008).","journal-title":"Diabetes"},{"issue":"17","key":"28358_CR90","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.113.007913","volume":"129","author":"SY Tang","year":"2014","unstructured":"Tang, S. Y. et al. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation 129 (17), 1761\u20131769 (2014).","journal-title":"Circulation"},{"key":"28358_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2013.09.008","volume":"78","author":"A Martelli","year":"2013","unstructured":"Martelli, A. et al. The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction. Pharmacol. Res. 78, 1\u20139 (2013).","journal-title":"Pharmacol. Res."},{"issue":"1","key":"28358_CR92","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s41065-025-00441-4","volume":"162","author":"H Xiao","year":"2025","unstructured":"Xiao, H., Ma, W., Zha, L., Xiao, Y. & Li, H. Curcumin alleviates LPS-induced WI-38 cell inflammation injury by regulating PTGS2 expression. Hereditas 162 (1), 81 (2025).","journal-title":"Hereditas"},{"issue":"1","key":"28358_CR93","doi-asserted-by":"publisher","first-page":"184","DOI":"10.12997\/jla.2020.9.1.184","volume":"9","author":"SE Lee","year":"2020","unstructured":"Lee, S. E., Park, H. R., Jeon, S., Han, D. & Park, Y. S. Curcumin attenuates Acrolein-induced COX-2 expression and prostaglandin production in human umbilical vein endothelial cells. J. Lipid Atheroscler. 9 (1), 184\u2013194 (2020).","journal-title":"J. Lipid Atheroscler"},{"issue":"6","key":"28358_CR94","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140 (6), 805\u2013820 (2010).","journal-title":"Cell"},{"issue":"7","key":"28358_CR95","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2017.17","volume":"24","author":"P Cohen","year":"2017","unstructured":"Cohen, P. & Strickson, S. The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways. Cell. Death Differ. 24 (7), 1153\u20131159 (2017).","journal-title":"Cell. Death Differ."},{"issue":"1","key":"28358_CR96","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12872-022-02755-x","volume":"22","author":"JY Luo","year":"2022","unstructured":"Luo, J. Y. et al. Association of NFKB1 gene rs28362491 mutation with the occurrence of major adverse cardiovascular events. BMC Cardiovasc. Disord. 22 (1), 313 (2022).","journal-title":"BMC Cardiovasc. Disord"},{"key":"28358_CR97","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mvr.2015.12.008","volume":"106","author":"W Li","year":"2016","unstructured":"Li, W., Suwanwela, N. C. & Patumraj, S. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I\/R. Microvasc Res. 106, 117\u2013127 (2016).","journal-title":"Microvasc Res."},{"issue":"4","key":"28358_CR98","first-page":"1223","volume":"116","author":"E Cre\u0163u","year":"2012","unstructured":"Cre\u0163u, E., Trifan, A., Vasincu, A. & Miron, A. Plant-derived anticancer agents - curcumin in cancer prevention and treatment. Rev. Med. Chir. Soc. Med. Nat. Iasi. 116 (4), 1223\u20131229 (2012).","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi"},{"issue":"4","key":"28358_CR99","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.112.112185","volume":"126","author":"SK Verma","year":"2012","unstructured":"Verma, S. K. et al. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent Inhibition of nuclear factor-\u03baB. Circulation 126 (4), 418\u2013429 (2012).","journal-title":"Circulation"},{"issue":"2","key":"28358_CR100","first-page":"111","volume":"1","author":"RA Knight","year":"2012","unstructured":"Knight, R. A., Scarabelli, T. M. & Stephanou, A. STAT transcription in the ischemic heart. Jakstat 1 (2), 111\u2013117 (2012).","journal-title":"Jakstat"},{"issue":"6","key":"28358_CR101","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-09-2468","volume":"70","author":"L Lin","year":"2010","unstructured":"Lin, L. et al. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Res. 70 (6), 2445\u20132454 (2010).","journal-title":"Cancer Res."},{"issue":"4 Pt 1","key":"28358_CR102","doi-asserted-by":"publisher","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","volume":"271","author":"BH Jiang","year":"1996","unstructured":"Jiang, B. H., Semenza, G. L., Bauer, C. & Marti, H. H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271 (4 Pt 1), C1172\u20131180 (1996).","journal-title":"Am. J. Physiol."},{"issue":"1","key":"28358_CR103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11306-025-02223-5","volume":"21","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Identification of potential biomarkers for coronary slow flow using untargeted metabolomics. Metabolomics 21 (1), 23 (2025).","journal-title":"Metabolomics"},{"key":"28358_CR104","doi-asserted-by":"publisher","first-page":"116289","DOI":"10.1016\/j.jep.2023.116289","volume":"308","author":"X Wu","year":"2023","unstructured":"Wu, X. et al. DiDang Decoction improves mitochondrial function and lipid metabolism via the HIF-1 signaling pathway to treat atherosclerosis and hyperlipidemia. J. Ethnopharmacol. 308, 116289 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"28358_CR105","doi-asserted-by":"publisher","first-page":"1524736","DOI":"10.3389\/fphar.2025.1524736","volume":"16","author":"X Wu","year":"2025","unstructured":"Wu, X. et al. Ferulic acid inhibits ox-LDL-induced ferroptosis and apoptosis in RAW 264.7 cells via the HIF-1 signaling pathway. Front. Pharmacol. 16, 1524736 (2025).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"28358_CR106","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jvs.2013.02.240","volume":"58","author":"CS Lim","year":"2013","unstructured":"Lim, C. S., Kiriakidis, S., Sandison, A., Paleolog, E. M. & Davies, A. H. Hypoxia-inducible factor pathway and diseases of the vascular wall. J. Vasc Surg. 58 (1), 219\u2013230 (2013).","journal-title":"J. Vasc Surg."},{"issue":"1","key":"28358_CR107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-018-0096-z","volume":"15","author":"FJ Gonzalez","year":"2018","unstructured":"Gonzalez, F. J., Xie, C. & Jiang, C. The role of hypoxia-inducible factors in metabolic diseases. Nat. Rev. Endocrinol. 15 (1), 21\u201332 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"28358_CR108","first-page":"1039","volume":"45","author":"D Li","year":"2025","unstructured":"Li, D. et al. [Curcumin inhibits lipid metabolism in non-small cell lung cancer by downregulating the HIF-1\u03b1 pathway]. Nan Fang Yi Ke Da Xue Xue Bao. 45 (5), 1039\u20131046 (2025).","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2","key":"28358_CR109","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0955-0674(00)00194-0","volume":"13","author":"GL Semenza","year":"2001","unstructured":"Semenza, G. L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell. Biol. 13 (2), 167\u2013171 (2001).","journal-title":"Curr. Opin. Cell. Biol."},{"issue":"4","key":"28358_CR110","first-page":"196","volume":"13","author":"Y Rasmi","year":"2017","unstructured":"Rasmi, Y. et al. Transcriptional activity of tumor necrosis factor-alpha gene in peripheral blood mononuclear cells in patients with coronary slow flow. ARYA Atheroscler. 13 (4), 196\u2013201 (2017).","journal-title":"ARYA Atheroscler"},{"key":"28358_CR111","doi-asserted-by":"crossref","unstructured":"Huang, J., Yang, Q., He, L. & Huang, J. Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. J Clin. Lab. Anal. 32(2),  e22232 (2018).","DOI":"10.1002\/jcla.22232"},{"key":"28358_CR112","doi-asserted-by":"publisher","first-page":"155541","DOI":"10.1016\/j.cyto.2021.155541","volume":"143","author":"AM Gorabi","year":"2021","unstructured":"Gorabi, A. M. et al. Effect of Curcumin on Proinflammatory cytokines: A meta-analysis of randomized controlled trials. Cytokine 143, 155541 (2021).","journal-title":"Cytokine"},{"key":"28358_CR113","doi-asserted-by":"crossref","unstructured":"Kaur, S., Bhatti, G. K., Khullar, N. & Bhatti, J. S. Targeting mitochondrial MicroRNAs in cardiovascular pathologies: A new frontier in precision cardiology. Ageing Res. Rev. 102920,  16 (2025).","DOI":"10.1016\/j.arr.2025.102920"},{"key":"28358_CR114","doi-asserted-by":"publisher","first-page":"6345284","DOI":"10.1155\/2018\/6345284","volume":"2018","author":"Q Su","year":"2018","unstructured":"Su, Q., Yang, H. & Li, L. Circulating miRNA-155 as a potential biomarker for coronary slow flow. Dis. Markers. 2018, 6345284 (2018).","journal-title":"Dis. Markers"},{"key":"28358_CR115","doi-asserted-by":"crossref","unstructured":"Chen, T., Wang, Z. Y. & Li, C. C. miRNA-22 as a Candidate Diagnostic Biomarker for Coronary Slow Flow. Cardiol Res Pract. ; 2020: 7490942. (2020).","DOI":"10.1155\/2020\/7490942"},{"issue":"17","key":"28358_CR116","first-page":"1323","volume":"99","author":"L Wang","year":"2019","unstructured":"Wang, L., Wang, H. N. & Zu, X. L. [Relationship between plasma miR-126 and coronary slow flow phenomenon]. Zhonghua Yi Xue Za Zhi. 99 (17), 1323\u20131327 (2019).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"28358_CR117","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.1038\/s41598-024-58745-w","volume":"14","author":"L Sun","year":"2024","unstructured":"Sun, L. et al. Differential gene expression and MiRNA regulatory network in coronary slow flow. Sci. Rep. 14 (1), 8419 (2024).","journal-title":"Sci. Rep."},{"issue":"4","key":"28358_CR118","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1159\/000430303","volume":"36","author":"Y Yang","year":"2015","unstructured":"Yang, Y., Yang, L., Liang, X. & Zhu, G. MicroRNA-155 promotes atherosclerosis inflammation via targeting SOCS1. Cell. Physiol. Biochem. 36 (4), 1371\u20131381 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"28358_CR119","doi-asserted-by":"publisher","first-page":"106841","DOI":"10.1016\/j.vph.2021.106841","volume":"138","author":"C Zhao","year":"2021","unstructured":"Zhao, C. et al. The LncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis. Vascul Pharmacol. 138, 106841 (2021).","journal-title":"Vascul Pharmacol."},{"issue":"5","key":"28358_CR120","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.7150\/ijbs.31099","volume":"15","author":"B Mo","year":"2019","unstructured":"Mo, B. et al. miR-30e-5p mitigates Hypoxia-Induced apoptosis in human stem Cell-Derived cardiomyocytes by suppressing Bim. Int. J. Biol. Sci. 15 (5), 1042\u20131051 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"28358_CR121","doi-asserted-by":"crossref","unstructured":"Sun, L., Zhang, Y., Zhang, J., Wang, J. & Xing, S. Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221\/VEGFA axis. Biosci Rep. 40(11), BSR20193053 (2020).","DOI":"10.1042\/BSR20193053"},{"key":"28358_CR122","doi-asserted-by":"crossref","unstructured":"Chistiakov, D. A., SobeninI, A., Orekhov, A. N. & Bobryshev, Y. V. Human miR-221\/222 in physiological and atherosclerotic vascular remodeling. Biomed. Res. Int. 2015, 354517 (2015).","DOI":"10.1155\/2015\/354517"},{"issue":"1","key":"28358_CR123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1570161114666160914175149","volume":"15","author":"T Celic","year":"2017","unstructured":"Celic, T., Metzinger-Le Meuth, V., Six, I., Massy, Z. A. & Metzinger, L. The mir-221\/222 cluster is a key player in vascular biology via the Fine-Tuning of endothelial cell physiology. Curr. Vasc Pharmacol. 15 (1), 40\u201346 (2017).","journal-title":"Curr. Vasc Pharmacol."},{"issue":"1","key":"28358_CR124","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11033-025-11050-9","volume":"52","author":"A Anwar","year":"2025","unstructured":"Anwar, A. & Khan, M. J. Pathogenic and clinical significance of inflammation-associated MicroRNAs in cardiovascular diseases. Mol. Biol. Rep. 52 (1), 940 (2025).","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"28358_CR125","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13000-024-01468-3","volume":"19","author":"T Eslaminejad","year":"2024","unstructured":"Eslaminejad, T., Nematollahi-Mahani, S. N., Sargazi, M. L., Ansari, M. & Mirzaie, V. Evaluating the effects of Curcumin nano-chitosan on miR-221 and miR-222 expression and Wnt\/\u03b2-catenin pathways in MCF-7, MDA-MB-231 and SKBR3 cell lines. Diagn. Pathol. 19 (1), 35 (2024).","journal-title":"Diagn. Pathol."},{"key":"28358_CR126","doi-asserted-by":"publisher","first-page":"e16593","DOI":"10.7717\/peerj.16593","volume":"11","author":"S Li","year":"2023","unstructured":"Li, S. et al. Inhibition of hepatocellular carcinoma growth via modulation of the miR-221\/SOX11 axis by Curcumin and Berberine. PeerJ 11, e16593 (2023).","journal-title":"PeerJ"},{"key":"28358_CR127","doi-asserted-by":"publisher","first-page":"9347381","DOI":"10.1155\/2024\/9347381","volume":"2024","author":"S Mazaheri-Tehrani","year":"2024","unstructured":"Mazaheri-Tehrani, S., Rouzbahani, S. & Heidari-Beni, M. The association between Anti-Neoplastic effects of Curcumin and urogenital cancers: A systematic review. Biomed. Res. Int. 2024, 9347381 (2024).","journal-title":"Biomed. Res. Int."},{"issue":"7","key":"28358_CR128","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1002\/jcp.26301","volume":"233","author":"S Dolati","year":"2018","unstructured":"Dolati, S. et al. Nanocurcumin restores aberrant MiRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial. J. Cell. Physiol. 233 (7), 5222\u20135230 (2018).","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"28358_CR129","doi-asserted-by":"publisher","first-page":"e14407","DOI":"10.1111\/jfbc.14407","volume":"46","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q., Deng, B., Akbari, A., Liu, Q. & Zhu, B. The ketogenic diet could improve the efficacy of Curcumin and Oldenlandia diffusa extract in the treatment of gastric cancer by increasing miR340 expression and apoptosis mediated by autophagy, oxidative stress, and angiogenesis. J. Food Biochem. 46 (12), e14407 (2022).","journal-title":"J. Food Biochem."},{"issue":"2","key":"28358_CR130","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3892\/ol.2017.6321","volume":"14","author":"D Yang","year":"2017","unstructured":"Yang, D., Li, Y. & Zhao, D. Curcumin induces apoptotic cell death in human pancreatic cancer cells via the miR-340\/XIAP signaling pathway. Oncol. Lett. 14 (2), 1811\u20131816 (2017).","journal-title":"Oncol. Lett."},{"issue":"10","key":"28358_CR131","doi-asserted-by":"publisher","first-page":"13177","DOI":"10.1007\/s13277-016-5221-9","volume":"37","author":"Q Sun","year":"2016","unstructured":"Sun, Q. et al. Curcumin inhibits cell growth and induces cell apoptosis through upregulation of miR-33b in gastric cancer. Tumour Biol. 37 (10), 13177\u201313184 (2016).","journal-title":"Tumour Biol."},{"issue":"3","key":"28358_CR132","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.toxlet.2015.02.018","volume":"234","author":"P Zhang","year":"2015","unstructured":"Zhang, P. et al. MicroRNA-33b, upregulated by EF24, a Curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2. Toxicol. Lett. 234 (3), 151\u2013161 (2015).","journal-title":"Toxicol. Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28358-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28358-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:05:14Z","timestamp":1777388714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28358-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28358"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28358-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44551"}}